Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

This study is currently recruiting participants.

Verified by Louisiana State University, December 2007

First Received: January 4, 2008 No Changes Posted

Sponsored by:	Louisiana State University
Information provided by:	Louisiana State University
ClinicalTrials.gov Identifier:	NCT00596180

Purpose

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Condition	Intervention	Phase
Non-Acute Carbon Monoxide Poisoning	Drug: HBOT	Phase I

Study Type:	Interventional
Study Design:	Treatment, Open Label, Single Group Assignment, Efficacy Study
Official Title:	Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Resource links provided by NLM:

MedlinePlus related topics: Carbon Monoxide Poisoning Poisoning

Drug Information available for: Carbon monoxide

U.S. FDA Resources

Further study details as provided by Louisiana State University:

Primary Outcome Measures:

SPECT brain imaging [ Time Frame: after completion of HBOT ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

clinical history and physical exam [ Time Frame: after completion of HBOT ] [ Designated as safety issue: No ]

Estimated Enrollment:	30
Study Start Date:	January 2007
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental HBOT	Drug: HBOT total body exposure to greater than atmospheric pressure oxygen

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion Criteria:

None.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00596180

Contacts

Contact: Paul G Harch, M.D.

504-366-1445

paulharchmd@aol.com

Locations

United States, Louisiana
Family Physicians Center	Recruiting
Marrero, Louisiana, United States, 70072
Contact: Paul G Harch, M.D. 504-366-1445 paulharchmd@aol.com
Principal Investigator: Paul G Harch, M.D.

Sponsors and Collaborators

Louisiana State University

Investigators

Principal Investigator:

Paul G Harch, M.D.

LSU School of Medicine

More Information

No publications provided

Responsible Party:	LSU School of Medicine ( Paul G. Harch, M.D. )
Study ID Numbers:	LSU IRB #6626
Study First Received:	January 4, 2008
Last Updated:	January 4, 2008
ClinicalTrials.gov Identifier:	NCT00596180 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Louisiana State University:

carbon monoxide poisoning
brain injury

Study placed in the following topic categories:

Antimetabolites
Carbon Monoxide Poisoning
Poisoning
Carbon Monoxide

Disorders of Environmental Origin
Flatulence
Brain Injuries

Additional relevant MeSH terms:

Antimetabolites
Molecular Mechanisms of Pharmacological Action
Carbon Monoxide Poisoning
Poisoning

Carbon Monoxide
Disorders of Environmental Origin
Gas Poisoning
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 11, 2009